Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced the upcoming presentation of discovery and development data for BSI-038, an anti-CD40 agonistic antibody at the...

Presentations to Highlight Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, May 8, 2023 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage...

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: BofA Securities 2023 Health Care Conference Fireside Chat Date: Wednesday, May 10,...

Vibrant Gastro, a medical technology company that developed an FDA-cleared drug-free treatment for chronic idiopathic constipation (CIC) in adults, presented an abstract at the 2023 Digestive...

– Findings from two clinical study presentations in adults with HRS involving rapid reduction in kidney function1 provide insight into the appropriate use of terlipressin for the care of...